pharma news today obesity drugs glp-1 today What is the pipeline for future medications for obesity? health pharma news today obesity
Description
Food-Grade Mulberry Powder Enriched With 1-Deoxynojirimycin Suppresses the Elevation of Postprandial Blood Glucose in Humans
The STEP 4 trial showed participants regained approximately two-thirds of their lost weight within one year of discontinuation
Disadvantages, compared to sitagliptin, include an injectable dosage form and gastrointestinal side effects
Hagstrom, J
and Carey, EJ., 2024
